Does the below statement mean that even if the worst case scenario in the roche litigation were to occur medisys would not be further inconvenienced as they are about change the assure profile to it's proprietary biosensor technology?.
from yesterdays statement.
In addition, early in 2006, the Group will introduce its new Assure Pro blood
glucose monitoring system. Assure Pro is based on the Group's proprietary
biosensor technology and has been developed specifically for use in the clinical environment. It is anticipated that the advanced feature set of the Assure Pro will provide the Group with the opportunity to re-build its margins in the LTC segment
Midcap Spdrs stock quotes
Midcap Spdrs stock charts
Follow this thread
